Global Huntington’s Disease Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Huntington’s Disease Treatment Market Research Report 2024
Medications for movement disorders. Drugs to treat movement disorders include the followingTetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
According to MRAResearch’s new survey, global Huntington’s Disease Treatment market is projected to reach US$ 1532.3 million in 2033, increasing from US$ 225.2 million in 2022, with the CAGR of 30.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Huntington’s Disease Treatment market research.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Huntington’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Segment by Type
Symptomatic Therapy
Disease-Modifying Therapy
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Huntington’s Disease Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Huntington’s Disease Treatment market is projected to reach US$ 1532.3 million in 2033, increasing from US$ 225.2 million in 2022, with the CAGR of 30.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Huntington’s Disease Treatment market research.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Huntington’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Segment by Type
Symptomatic Therapy
Disease-Modifying Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Huntington’s Disease Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source